Načítá se...
Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions
Dysregulation of hepcidin, a key iron regulating hormone, is important in the pathogenesis of iron overload in patients with myelodysplatic syndrome (MDS). However, most studies of hepcidin levels are complicated by concomitant RBC transfusions. To evaluate the relationship between iron metabolism a...
Uloženo v:
Vydáno v: | Leuk Res |
---|---|
Hlavní autoři: | , , , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
2014
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4439195/ https://ncbi.nlm.nih.gov/pubmed/24598841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2014.01.016 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|